risankizumab
abbvie
['risan', 'crohn']
ferrante presented nice data on #risankizumab with respect to prior biologic use in #crohnsdisease. regardless of # prior biologic rzb showed efficacy, 360mg likely better with 2 or 3 prior meds for maint. small subset with prior ust also responded, no new safety signal #acg2022
Clinical Director of Translational Research, Jill Roberts Center for #IBD @nyphospital @WeillCornell Tweets are mine but not = endorsement or medical advice.